Unknown

Dataset Information

Photoactivated cell-killing involving a low molecular weight, donor-acceptor diphenylacetylene.


ABSTRACT: Photoactivation of photosensitisers can be utilised to elicit the production of ROS, for potential therapeutic applications, including the destruction of diseased tissues and tumours. A novel class of photosensitiser, exemplified by DC324, has been designed possessing a modular, low molecular weight and 'drug-like' structure which is bioavailable and can be photoactivated by UV-A/405 nm or corresponding two-photon absorption of near-IR (800 nm) light, resulting in powerful cytotoxic activity, ostensibly through the production of ROS in a cellular environment. A variety of in vitro cellular assays confirmed ROS formation and in vivo cytotoxic activity was exemplified via irradiation and subsequent targeted destruction of specific areas of a zebrafish embryo.

SUBMITTER: Chisholm DR 

PROVIDER: S-EPMC6495688 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature